841 results on '"HUMAN herpesvirus 2"'
Search Results
202. Recommendations for the Selective Use of Herpes Simplex Virus Type 2 Serological Tests
203. Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea
204. Induction of Antiviral Immunity Requires Toll-Like Receptor Signaling in Both Stromal and Dendritic Cell Compartments
205. Longitudinal Risk of Herpes Simplex Virus (HSV) Type 1, HSV Type 2, and Cytomegalovirus Infections among Young Adolescent Girls
206. Calculating the Contribution of Herpes Simplex Virus Type 2 Epidemics to Increasing HIV Incidence: Treatment Implications
207. Mutations in Herpes Simplex Virus Glycoprotein D That Prevent Cell Entry Via Nectins and Alter Cell Tropism
208. Herpes Simplex Virus Type 2 as a Cause of Severe Meningitis in Immunocompromised Adults
209. Immunodominance among Herpes Simplex Virus-Specific CD8 T Cells Expressing a Tissue-Specific Homing Receptor
210. Herpes Simplex Virus Triggers Activation of Calcium-Signaling Pathways
211. Socio-Demographic Characteristics and Sex Practices Related to Herpes Simplex Virus Type 2 Infection in Mexican and Central American Female Sex Workers
212. Association of Hepatitis C Virus Infection with Sexual Exposure in Southern India
213. Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis
214. A Prospective Study of Genital Herpes Simplex Virus Type 2 Infection in Human Immunodeficiency Virus Type 1 (HIV-1)-Seropositive Women: Correlations with CD4 Cell Count and Plasma HIV-1 RNA Level
215. Serological Testing for Herpes Simplex Virus (HSV)-1 and HSV-2 Infection
216. Differences in Laboratory Findings for Cerebrospinal Fluid Specimens Obtained from Patients with Meningitis or Encephalitis Due to Herpes Simplex Virus (HSV) Documented by Detection of HSV DNA
217. Antiviral Susceptibility of Herpes Simplex Viruses and Its Clinical Correlates: A Single Center's Experience
218. Two-Day Regimen of Acyclovir for Treatment of Recurrent Genital Herpes Simplex Virus Type 2 Infection
219. Herpes Simplex Virus Shedding and Plasma Human Immunodeficiency Virus RNA Levels in Coinfected Women
220. Risk Factors of Herpes Simplex Type 1 (HSV-1) Infection and Lifestyle Factors Associated with HSV-1 Manifestations
221. Herpes Simplex Virus Type-2 Antibodies in Pregnant Women: The Impact of the Stage of Pregnancy
222. Prevalence of Sexually Transmitted Infections and Associated Risk Factors among Populations of Drug Abusers
223. Prospects for Control of Herpes Simplex Virus Disease through Immunization
224. High Prevalence of Varicella-Zoster Virus Reactivation in Herpes Simplex Virus-Seronegative Patients with Acute Peripheral Facial Palsy
225. Herpes Simplex Virus DNA in Amniotic Fluid without Neonatal Infection
226. Herpes Simplex Virus Type 2 Shedding in Human Immunodeficiency Virus-Negative Men Who Have Sex with Men: Frequency, Patterns, and Risk Factors
227. Immunization against Genital Herpes with a Vaccine Virus That has Defects in Productive and Latent Infection
228. New Therapies and Prevention Strategies for Genital Herpes
229. Herpes Simplex Virus Infections of the Central Nervous System in Human Immunodeficiency Virus-Infected Patients: Clinical Management by Polymerase Chain Reaction Assay of Cerebrospinal Fluid
230. An Epidemiologic Study of Herpes Simplex Virus Type 1 and 2 Infection in Japan Based on Type-Specific Serological Assays
231. Perspectives on Switching Oral Acyclovir from Prescription to Over-the-Counter Status: Report of a Consensus Panel
232. Herpes Simplex Viruses
233. Coagulation Initiated on Herpesviruses
234. Severe Genital Herpes Infections in HIV-Infected Individuals with Impaired Herpes Simplex Virus-Specific CD8 + Cytotoxic T Lymphocyte Responses
235. Fulminant Hepatitis during Herpes Simplex Virus Infection in Apparently Immunocompetent Adults: Report of Two Cases and Review of the Literature
236. Seroprevalence of Herpes Simplex Virus Types 1 and 2 and Cytomegalovirus in Adolescents
237. Immunization with DNA Vaccines Encoding Glycoprotein D or Glycoprotein B, Alone or in Combination, Induces Protective Immunity in Animal Models of Herpes Simplex Virus-2 Disease
238. Induction of Cytotoxic T Lymphocytes by Intramuscular Immunization with Plasmid DNA is Facilitated by Bone Marrow-Derived Cells
239. Disseminated Herpesvirus Infection during Pregnancy
240. Increase in STI Risk Seen For Women Using Injectable Contraceptives
241. Herpes genitalis and the philosopher's stance
242. A Case of Ramsay Hunt-Like Syndrome Caused by Herpes Simplex Virus Type 2
243. HSV-2 showcased: NAVY TESTS COUNTERMINE TECHNOLOGY IN MAJOR MINECLEARING EXERCISE
244. In addition to plans for DD(X) . . .: COHEN FLOATS IDEA OF BACKFITTING DDG-51 DESTROYERS WITH RAIL GUNS
245. Question of OSD post remains: NAVY ACQUISITION CHIEF QUASHES RUMORS OF DEPARTURE PLANS, RECUSALS
246. Epidemiology of Genital Herpes (HSV-2) among Brothel Based Female Sex Workers in Bangladesh
247. Domino Effects from Battles against Microbes
248. Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells
249. Valacyclovir Therapy Does Not Reverse Herpes-Associated Alterations in Cervical Immunology: A Randomized, Placebo-Controlled Crossover Trial
250. Population-Based Surveillance of Neonatal Herpes Simplex Virus Infection in Australia, 1997–2011
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.